Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0009
0.00 (0.00%)
Nov 3, 2025, 4:00 PM EST
Affymax Market Cap
Affymax has a market cap or net worth of $67.04 thousand as of November 4, 2025. Its market cap has decreased by -85.48% in one year.
Market Cap
67.04K
Enterprise Value
n/a
Revenue
42.00K
Ranking
n/a
PE Ratio
0.01
Stock Price
$0.00
Market Cap Chart
Since December 15, 2006, Affymax's market cap has decreased from 484.83M to 67.04K, a decrease of -99.99%. That is a compound annual growth rate of -37.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 67.04K | 12.50% |
| Dec 31, 2024 | 59.59K | 33.33% |
| Dec 29, 2023 | 44.69K | -85.00% |
| Dec 30, 2022 | 297.96K | -33.33% |
| Dec 31, 2021 | 446.94K | -94.00% |
| Dec 31, 2020 | 7.45M | 300.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |